BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5

• Press Releases

  Artelo Biosciences Announces Proposed Underwritten Public Offering

  September 4, 2025

   · 

  4 min read
• Press Releases

  Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025

  September 4, 2025

   · 

  1 min read
• Press Releases

  DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

  September 4, 2025

   · 

  2 min read
• Press Releases

  UPDATE -- vTv Therapeutics to Participate in Upcoming September 2025 Investor Conferences

  September 4, 2025

   · 

  1 min read
• Press Releases

  Sotera Health Announces Secondary Offering of Common Stock

  September 4, 2025

   · 

  2 min read
• Press Releases

  Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2

  September 4, 2025

   · 

  4 min read
• Press Releases

  SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

  September 4, 2025

   · 

  3 min read
• Press Releases

  Corstasis Therapeutics Announces Allowance of a New Patent and Development Updates for Subcutaneous Programs RSQ-786 and RSQ-789

  September 4, 2025

   · 

  2 min read
• Press Releases

  Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy

  September 4, 2025

   · 

  4 min read
• Press Releases

  Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients

  September 4, 2025

   · 

  11 min read